Further support for MYCN driven p53-dependent apoptosis being an important mechanism for tumor suppression in neuroblastoma comes from in vivo work using p53 or Mdm2 haploinsufficient models of neuroblastoma. The gene discussed is MDM2; the disease is neuroblastoma.